alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,876–6,900 of 7,816 matching trials · page 276 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
NCT01238991
ACC-001; ACC-001; ACC-001
Runs in: Japan · 11 sites 		PHASE2
other		 TERMINATED 53 Pfizer
INDUSTRY		 2014-12-22
Virtual Reality Based Balance Training in People With Mild Cognitive Impairment
NCT02214342
Balance Training
Runs in: United States · 1 site 		NA
other		 COMPLETED 20 University of Arizona
OTHER		 2014-12-16
Multidisciplinary Intervention for Challenging Behaviour (Agitation) in Patients With Dementia
NCT01183351
Psychosocial intervention
Runs in: Norway · 1 site 		NA
other		 COMPLETED 30 Sykehuset Innlandet HF
OTHER		 2014-12-12
Collaboration Between Department of Old Age Psychiatry and Nursing Homes
NCT01217541
Education and Supervision; Control
Runs in: Norway · 1 site 		NA
other		 COMPLETED 700 Sykehuset Innlandet HF
OTHER		 2014-12-12
The Effect of the Glycemic Load of Meals on the Cognition and Mood of Older Adults
NCT01842022
Isomaltulose; Sucrose; Glucose
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 155 Swansea University
OTHER		 2014-12-11
Cognitive/Physical Computer-Game Blended Training of Elderly: Neuroscientific LLM Studies
NCT02313935
LLM; FFA; Brain Fitness; VideoGrade 		NA
other		 COMPLETED 581 Aristotle University Of Thessaloniki
OTHER		 2014-12-11
Early Detection of Cognitive Dysfunction in Diabetes
NCT01830998
Runs in: China · 3 sites 		NA
other		 UNKNOWN 400 Wuhan General Hospital of Guangzhou Military Command
OTHER		 2014-12-10
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
NCT01283269
Memory Support System; Computer Training
Runs in: United States · 3 sites 		NA
other		 COMPLETED 128 Emory University
OTHER		 2014-12-04
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
NCT01573611
Grape Powder; Placebo Powder
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 12 University of California, Los Angeles
OTHER		 2014-12-04
Physical Exercise as an Additional Treatment for Alzheimer Disease
NCT01515982
Aerobic Exercise; Control Group
Runs in: Brazil · 1 site 		NA
other		 COMPLETED 20 Universidade Federal do Rio de Janeiro
OTHER		 2014-12-03
Effects of an Exercise Program for Nursing Home Patients With Dementia
NCT02262104
Intensive exercise; Control
Runs in: Norway · 1 site 		NA
other		 COMPLETED 170 Oslo Metropolitan University
OTHER		 2014-12-03
The HIP-HOP Flooring Study: Helping Injury Prevention in Hospitalised Older People
NCT00817869
New flooring
Runs in: United Kingdom · 8 sites 		NA
other		 COMPLETED 571 University of Portsmouth
OTHER		 2014-12-02
Effect of Physical Exercise in Alzheimer Patients
NCT01681602
Aerobic exercise
Runs in: Denmark · 1 site 		PHASE3
other		 COMPLETED 200 Rigshospitalet, Denmark
OTHER		 2014-12-02
Home Evaluation of Exit Barriers in Wandering
NCT00997425
Door cover/Floor cover
Runs in: United States · 1 site 		NA
other		 COMPLETED 19 US Department of Veterans Affairs
OTHER_GOV		 2014-11-21
F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
NCT01382849
Runs in: Canada · 1 site 		NA
other		 WITHDRAWN 0 Sunnybrook Health Sciences Centre
OTHER		 2014-11-19
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01527916
placebo; donepezil; ABT-126
Runs in: Poland; Russia; South Africa; Ukraine; United Kingdom; Un... · 33 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 438 AbbVie (prior sponsor, Abbott)
INDUSTRY		 2014-11-19
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
NCT01374438
MSDC-0160; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 29 Metabolic Solutions Development Company
INDUSTRY		 2014-11-18
Outcome Predictors of a Cognitive Intervention in aMCI
NCT01525368
cognitive intervention
Runs in: Germany · 1 site 		NA
other		 COMPLETED 110 Ludwig-Maximilians - University of Munich
OTHER		 2014-11-13
Dexmedetomidine to Prevent Agitation After Free Flap Surgery
NCT01904760
Dexmedetomidine; Saline placebo
Runs in: China · 1 site 		PHASE4
other		 COMPLETED 80 Peking University
OTHER		 2014-11-13
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo
NCT01827982
JNJ-54861911 1mg; JNJ-54861911 3 mg; JNJ-54861911 9 mg; JNJ-5486191...
Runs in: Belgium · 1 site 		PHASE1
other		 COMPLETED 56 Janssen Research & Development, LLC
INDUSTRY		 2014-11-10
Automated Brain Morphometry for Dementia Diagnosis
NCT02286505
Brain Morphometry; Standard radiological assessment
Runs in: United Kingdom · 1 site 		NA
other		 UNKNOWN 80 King's College London
OTHER		 2014-11-07
Caloric Restriction in Obese Patients With Mild Cognitive Impairment: Effects on Adiposity, Comorbidity and Cognition
NCT01286389
medical care; caloric restriction
Runs in: Brazil · 1 site 		NA
other		 COMPLETED 80 University of Sao Paulo General Hospital
OTHER		 2014-11-05
Mechanisms of Insulin Facilitation of Memory
NCT01145482
Insulin; Saline
Runs in: United States · 1 site 		NA
other		 COMPLETED 12 University of Texas at Austin
OTHER		 2014-11-03
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT01549834
ABT-126; ABT-126; placebo
Runs in: Canada; France; Germany; Greece; South Africa; United Kin... · 43 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 434 AbbVie (prior sponsor, Abbott)
INDUSTRY		 2014-10-31
Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients
NCT00110552
Salvia officinalis (sage)
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 111 Oregon Health and Science University
OTHER		 2014-10-29

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →